Table 1.

Individual variation of clinical scores, concurrent viral excretion and acute phase proteins in FIV, FeLV and FIV/FeLV cats treated with rFeIFN‐ω

Cats	FIV/FeLV status	Clinical scores (D0 versus D65)	Concurrent viral excretion (individual tendency D0 versus D65)				Acute phase proteins (individual tendency D0 versus D65)
			Calicivirus	Herpesvirus	Coronavirus	Parvovirus	SAA	AGP	CRP
1	FIV	↓	BN	↓	↓	−	↑	↑	↑
2	FIV	→	−	↓	−	−	↑	↑	↑
3	FIV	↓	−	↓	↓	−	↑	↑	↑
4	FIV	↓	BN	*	↑	−	↑	↑	↑
5	FIV	↓	−	↓	−	−	↑	↑	↑
6	FIV	↓	BN	−	↓	−	↓	↑	↑
7	FIV	→	BN	−	↓	−	↑	↓	↑
8	FeLV	→	BN	↓	↓	−	↑	↑	↑
9	FeLV	→	BN	↓	*	−	↑	↑	↑
10	FeLV	↓	BN	*	↑	−	↑	↑	↑
11	FeLV	↓	BN	*	*	−	↑	↑	↑
12	FeLV	→	BN	↓	↓	−	↑	↓	↑
13	FeLV	↓	BN	↓	↓	−	↑	↓	↑
14	FIV/FeLV	↓	BN	−	↓	−	↑	↑	↑
15	FIV/FeLV	→	BN	↓	*	−	↑	↑	↑
16	FIV/FeLV	↓	BN	↓	↓	BN	↑	↑	↑

Comparing D0 (before) to D65 (end of the therapy): (↓) refers to a decrease of the parameter; () refers to an increase of the parameter; (→) refers to a stable parameter; (−) refers to negative samples; (*) refers to intermittent excretion during therapy, despite a negative result at D0 and D65. (BN) refers to animals that were positive at D0 and became negative during therapy. Regarding Clinical Scores, a reduction of the parameter refers to a clinical improvement. FIV feline immunodeficiency virus, FeLV feline leukemia virus, rFeIFN‐ω Recombinant feline interferon‐ω